Colin Neate is an experienced biostatistics leader in clinical drug development, currently on downtime prior to moving back to the UK and seeking new opportunities. Colin served as a statistician at GlaxoSmithKline from 2000 to 2006 and later took on roles at Roche, including Associate Director of Oncology Biostatistics, where they led teams and contributed to oncology drug development. Colin's extensive experience encompasses project leadership, regulatory interactions, and mentoring, particularly focusing on solid tumor oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices